A carregar...
Growth inhibitory effect of the Src inhibitor dasatinib in combination with anticancer agents on uterine cervical adenocarcinoma cells
Uterine cervical adenocarcinoma has a poor clinical prognosis when compared with squamous cell carcinoma. Therefore, the development of new treatment strategies for uterine cervical adenocarcinoma is necessary. Src is a proto-oncogene that is important in cancer progression. Dasatinib is a Src inhib...
Na minha lista:
| Publicado no: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5647549/ https://ncbi.nlm.nih.gov/pubmed/29067110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.5061 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|